A detailed history of Jpmorgan Chase & CO transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 22,994 shares of SLP stock, worth $632,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,994
Previous 27,382 16.03%
Holding current value
$632,105
Previous $1.13 Million 0.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$38.46 - $50.95 $168,762 - $223,568
-4,388 Reduced 16.03%
22,994 $1.12 Million
Q1 2024

May 10, 2024

BUY
$37.48 - $44.74 $41,040 - $48,990
1,095 Added 4.17%
27,382 $1.13 Million
Q4 2023

Feb 12, 2024

BUY
$33.36 - $45.71 $31,625 - $43,333
948 Added 3.74%
26,287 $1.18 Million
Q3 2023

Nov 14, 2023

SELL
$40.03 - $51.51 $4,723 - $6,078
-118 Reduced 0.46%
25,339 $1.06 Million
Q2 2023

Aug 11, 2023

BUY
$40.45 - $48.0 $95,906 - $113,808
2,371 Added 10.27%
25,457 $1.1 Million
Q1 2023

May 18, 2023

BUY
$34.96 - $43.94 $418,261 - $525,698
11,964 Added 107.57%
23,086 $1.01 Million
Q1 2023

May 11, 2023

SELL
$34.96 - $43.94 $266,115 - $334,471
-7,612 Reduced 40.63%
11,122 $488,000
Q4 2022

Feb 13, 2023

BUY
$36.55 - $51.15 $64,291 - $89,972
1,759 Added 10.36%
18,734 $685,000
Q3 2022

Nov 14, 2022

SELL
$47.75 - $66.88 $1.66 Million - $2.32 Million
-34,740 Reduced 67.18%
16,975 $824,000
Q2 2022

Aug 11, 2022

BUY
$40.55 - $51.76 $11,516 - $14,699
284 Added 0.55%
51,715 $2.55 Million
Q1 2022

May 11, 2022

BUY
$36.56 - $50.98 $1.51 Million - $2.1 Million
41,286 Added 406.96%
51,431 $2.62 Million
Q4 2021

Feb 10, 2022

SELL
$37.1 - $57.45 $309,228 - $478,845
-8,335 Reduced 45.1%
10,145 $480,000
Q3 2021

Nov 12, 2021

BUY
$38.45 - $55.66 $710,556 - $1.03 Million
18,480 New
18,480 $730,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $558M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.